Press release

INVEST SECURITIES & INVEST CORPORATE FINANCE ASSISTED BIOPHYTIS FOR THE COMPLETION OF A PRIVATE PLACEMENT OF €3.7M AND THE ARRANGEMENT OF A BOND FINANCING OF €15M   In this transaction, Invest Securities intervened as Bookrunner and Invest Corporate Finance intervened as Adviser for the Transaction. A biotechnology company listed on the Alternext market of Euronext […]

This increase in capital allows TxCell to pursue the development of innovative technologies against autoimmune diseases and transplant rejections. In this operation, Invest Securities intervened as Lead Arranger and Bookrunner and Invest Corporate Finance intervened as adviser to the company.   A biotechnology company listed on Euronext, TxCell develops innovative personalised cell immunotherapies from T regulating […]

 A long term partnership to develop the new 3D printing technologies in construction   XtreeE was advised in this transaction by Invest Corporate Finance VINCI Construction becomes a shareholder, alongside other investors, and signs a partnership contract with XtreeE, a French start-up among the global leaders in 3D concrete printing. This partnership is combined with […]

The Invest Securities Group is now adopting a new identity and combines all of its businesses under the trade name Allinvest. This new name illustrates the dimension taken on by the company since 2014 (accelerated development, internationalisation, takeovers and diversification) and marks the move to a new stage in its development. Allinvest thus confirms its […]